ArticleFrontiers in cardiovascular medicine2025
Transthoracic echocardiography-guided subaortic ventricular septal defect closure in infants: a case report.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Subaortic VSD, while similar to perimembranous defects, pose a higher risk for aortic valve insufficiency and AV block. This case aims to assess the safety and efficacy of percutaneous subaortic VSD closure in infants under 10 kg using transthoracic echocardiography-only guidance. Case presentation: A one-year-old infant, 8.9 kg, was scheduled for subaortic VSD closure due to concerns of failure to thrive. Percutaneous closure was performed using a retrograde transarterial approach with a 7/5 mm Konar-MF VSD Occluder (Lifetech) under TTE guidance. Apical 5-chamber view showed smallest VSD diameter 3.8 mm. 3.5/5F Guiding JR catheter with soft hydrophilic wire were then maneuvered to descending aorta in subxiphoid 12 o'clock view, suprasternal short axis view and positioned just above the aortic valve. Catheter was then entered to the LV shown by parasternal long axis view. 3.5/5F Guiding JR catheter was then crossed the subaortic VSD in parasternal short axis view. The Konar-MF VSD Occluder (Lifetech) No. 7/5 mm was deployed assisted by apical 5-chamber view. Device detachment was then evaluated in parasternal short axis view showing no residual shunt. At six-month follow-up, the device was well seated, and the symptoms subsided. Conclusions: Our case underscores that zero-fluoroscopy TTE-only percutaneous subaortic VSD closure is feasible in selected patients under 10 kg with no major complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.